New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) Cagrilintide– Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) US$ 27.90 Min. order: 1 piece ★★★★★ 4.7 (199 reviews) Sold : Login>>
VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes US$ 26.84 Min. order: 1 piece ★★★★★ 4.9 (27 reviews) Sold : Login>>
VisualAbstract: Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials US$ 21.78 Min. order: 1 piece ★★★★★ 4.1 (116 reviews) Sold : Login>>
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial US$ 27.24 Min. order: 1 piece ★★★★★ 5.0 (274 reviews) Sold : Login>>
BPC 157 Benefits: Heal & Thrive in 2025 US$ 29.18 Min. order: 1 piece ★★★★★ 4.1 (31 reviews) Sold : Login>>